Idell S, James K K, Gillies C, Fair D S, Thrall R S
Department of Medicine, University of Texas Health Center, Tyler 75710.
Am J Pathol. 1989 Aug;135(2):387-99.
Alveolar fibrin deposition commonly accompanies acute lung injury, but the nature of the local abnormalities of coagulation and fibrinolysis that support pathologic fibrin deposition are not well understood. The trended abnormalities of procoagulant and fibrinolytic activities occurring in lung lavage fluids of Fischer 344 rats after lung injury induced by intravenous oleic acid (OA) or intratracheal bleomycin were studied. After injury by either agent, bronchoalveolar lavage (BAL) contained increased procoagulant activity and decreased fibrinolytic activity. Lavage procoagulant activity was mainly due to an activator of Factor X attributable to the extrinsic coagulation pathway, and fibrinolytic activity was almost completely plasminogen dependent. Major mechanisms of inhibition of fibrinolytic activity involved both the inhibition of the plasminogen activator (PA) and plasmin. These abnormalities were temporally associated with prominent alveolar fibrin deposition in both models. In OA-treated animals, lavage fibrinolytic activity was absent or profoundly decreased, and antiplasmin and procoagulant activities were increased within 4 hours after the induction of acute lung injury. By 24 hours after OA, lavage PA inhibitor (PAI) activity was elevated with sustained antiplasmin activity. By 3 days after OA, these abnormalities had resolved in association with almost complete resolution of alveolar fibrin deposits. Within 3 days after bleomycin-induced lung injury, lavage procoagulant activity was increased and fibrinolytic activity was depressed due to increased antiplasmin and PAI activities. These conditions persisted for 2 weeks, during which time alveolar fibrin deposition was associated with the development of pulmonary fibrosis. These data indicate that a disruption of the normal balance between procoagulant and fibrinolytic activities occurs in alveolar lining fluids of rats with alveolitis induced by either OA or bleomycin, and that concurrent abnormalities of pathways of fibrin turnover that occur in alveolar lining fluids promote the alveolar fibrin deposition associated with these lung injuries.
肺泡纤维蛋白沉积常伴随急性肺损伤,但支持病理性纤维蛋白沉积的局部凝血和纤维蛋白溶解异常的本质尚未完全清楚。我们研究了静脉注射油酸(OA)或气管内注射博来霉素诱导肺损伤后,Fischer 344大鼠肺灌洗液中促凝和纤溶活性的动态异常。在用任何一种药物损伤后,支气管肺泡灌洗(BAL)液中的促凝活性增加而纤溶活性降低。灌洗促凝活性主要归因于外源性凝血途径的X因子激活剂,而纤溶活性几乎完全依赖纤溶酶原。纤溶活性抑制的主要机制涉及纤溶酶原激活剂(PA)和纤溶酶的抑制。在两种模型中,这些异常都与显著的肺泡纤维蛋白沉积在时间上相关。在OA处理的动物中,急性肺损伤诱导后4小时内,灌洗纤溶活性缺失或显著降低,抗纤溶酶和促凝活性增加。OA处理后24小时,灌洗PA抑制剂(PAI)活性升高,抗纤溶酶活性持续存在。OA处理后3天,这些异常与肺泡纤维蛋白沉积物几乎完全消退相关。博来霉素诱导肺损伤后3天内,由于抗纤溶酶和PAI活性增加,灌洗促凝活性增加而纤溶活性降低。这些情况持续2周,在此期间肺泡纤维蛋白沉积与肺纤维化的发展相关。这些数据表明,在由OA或博来霉素诱导的肺泡炎大鼠的肺泡衬液中,促凝和纤溶活性之间的正常平衡被打破,并且肺泡衬液中发生的纤维蛋白周转途径的同时异常促进了与这些肺损伤相关的肺泡纤维蛋白沉积。